STOCK TITAN

Evolent Health Announces Dan McCarthy Appointed as President, Frank J. Williams to Retire from Evolent's Board of Directors in 2023

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
management
Rhea-AI Summary

Evolent Health (NYSE: EVH) announced Dan McCarthy's appointment as President, effective September 15, 2022. McCarthy, formerly CEO of New Century Health, will lead value-based specialty operations and oversee the integration of recent acquisitions into Evolent's platform. Frank J. Williams, co-founder and former CEO, will not seek re-election to the Board in June 2023. Both leaders emphasize a commitment to a seamless transition and continued growth.

Positive
  • Dan McCarthy's promotion as President may positively impact Evolent's strategy and operations.
  • McCarthy's focus on integrating IPG and Vital Decisions could enhance Evolent's value-based specialty platform.
Negative
  • Concerns regarding leadership continuity with Frank J. Williams retiring from the Board may affect investor confidence.

WASHINGTON, Sept. 6, 2022 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), announced today that New Century Health CEO Dan McCarthy has been named Evolent Health President, effective September 15, 2022. Mr. McCarthy will continue to oversee the company's value-based specialty operations and strategy and report directly to Evolent Health CEO Seth Blackley. Among Mr. McCarthy's immediate priorities will be completing the seamless integration of recent acquisitions IPG and Vital Decisions into Evolent's leading value-based specialty platform.

Mr. Blackley said, "For over eight years, Dan has played a critical leadership role at Evolent, driving our growth strategy, operations and clinical performance while building an extraordinary team. I look forward to working closely with Dan in expanding our value-based specialty platform and driving value for all our stakeholders."

Mr. McCarthy has served as CEO of New Century Health since 2019, and prior to that held multiple leadership roles within Evolent since joining the Company in 2014. Mr. McCarthy came to Evolent from McKinsey & Company, where he was a leader in the firm's health care practice. More details on Mr. McCarthy can be found here: https://www.evolenthealth.com/about-us/leadership-team/6268/dan-mccarthy

The Company also announced today that former Chairman and CEO Frank J. Williams, an Evolent co-founder, has informed the Board of Directors he will not stand for re-election at Evolent's next annual meeting of stockholders in June 2023.

Mr. Williams stated, "I could not be prouder of the work we have done at Evolent since our founding in 2011. It has been a privilege to be part of this amazing team and the value that we have created for our customers, patients, employees and shareholders. Across the coming months, I will continue to partner with Board Chair Cheryl Scott, Seth Blackley and the rest of the Evolent Board of Directors to ensure a smooth hand-off through our next shareholder meeting."

Mr. Blackley said, "Frank has been an outstanding leader for Evolent and an essential partner to me these past several years. We appreciate the smooth transition he has facilitated for Evolent's next chapter."

Cheryl Scott said, "I want to thank Frank for his tireless dedication and for his pride in Evolent's work for more than a decade. The Board appreciates the leadership Frank has provided as we embark on our next phase of leadership and growth at Evolent."

Evolent Health Logo (PRNewsfoto/Evolent Health)

About Evolent Health Evolent Health delivers proven clinical and administrative solutions that improve whole-person health while making health care simpler and more affordable. Our solutions encompass total cost of care management, specialty care management and administrative simplification. Evolent serves a national base of leading payers and providers, is the first company to receive the National Committee for Quality Assurance's Population Health Program Accreditation and is consistently recognized as a top place to work in health care nationally. Learn more about how Evolent is changing the way health care is delivered by visiting evolenthealth.com.

Contacts:
Seth R. Frank
Vice President, Investor Relations
Evolent Health, Inc.
sfrank@evolenthealth.com
571-895-3919 (W)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/evolent-health-announces-dan-mccarthy-appointed-as-president-frank-j-williams-to-retire-from-evolents-board-of-directors-in-2023-301618611.html

SOURCE Evolent Health

FAQ

Who is Dan McCarthy and what will be his role at Evolent Health?

Dan McCarthy has been appointed President of Evolent Health, focusing on value-based specialty operations and integration of recent acquisitions.

What does the leadership change at Evolent Health mean for the company?

The leadership change may bring new strategies under Dan McCarthy's presidency, but it raises concerns regarding continuity with Frank J. Williams retiring.

When will Frank J. Williams retire from Evolent Health's Board?

Frank J. Williams will not stand for re-election at the next annual meeting of stockholders in June 2023.

What is the significance of Dan McCarthy's prior experience for Evolent Health?

Dan McCarthy's experience in leadership roles at Evolent and New Century Health positions him well to drive growth and integrate acquisitions.

Evolent Health, Inc

NYSE:EVH

EVH Rankings

EVH Latest News

EVH Stock Data

1.29B
112.49M
3.95%
115.81%
9.41%
Health Information Services
Services-management Services
Link
United States of America
ARLINGTON